Table 4.
Meta-regression analysis by potential modifier res % residual variation due to heterogeneity.
| Biomarker | Covariate | Exp (b) | P-value | I2 res |
|---|---|---|---|---|
| FIB | Location | 1.20 (1.09–1.32) | 0.004 | 41.08% |
| Age | 0.94 (0.76–1.17) | 0.525 | 41.24% | |
| CVD type | 0.98 (0.91–1.06) | 0.555 | 73.16% | |
| Sample Size | 1.06 (0.85–1.32) | 0.525 | 41.24% | |
| IL-6 | Location | 1.00 (0.90–1.11) | 0.936 | 7.30% |
| Age | 0.96 (0.83–1.10) | 0.457 | 0.00% | |
| CVD type | 0.99 (0.95–1.03) | 0.516 | 0.24% | |
| Sample Size | 0.98 (0.84–1.13) | 0.705 | 5.16% | |
| CRP | Location | 0.98 (0.93–1.03) | 0.338 | 65.61% |
| Age | 0.97 (0.88–1.08) | 0.591 | 67.35% | |
| CVD type | 0.99 (0.97–1.01) | 0.405 | 65.11% | |
| Sample Size | 0.94 (0.86–1.00) | 0.143 | 61.82% | |
| Gal-3 | Location | 1.05 (0.94–1.16) | 0.379 | 10.41% |
| Age | 0.98 (0.89–1.09) | 0.747 | 14.66% | |
| CVD type | 1.00 (0.96–1.03) | 0.766 | 14.81% | |
| Sample Size | 0.92 (0.89–1.02) | 0.090 | 0.00% |